Page last updated: 2024-09-05

sb 216763 and Asthma

sb 216763 has been researched along with Asthma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bentley, JK; Bitar, KN; Deng, H; Dokshin, GA; Fingar, DC; Goldsmith, AM; Hershenson, MB; Lei, J1

Other Studies

1 other study(ies) available for sb 216763 and Asthma

ArticleYear
Inhibition of glycogen synthase kinase-3beta is sufficient for airway smooth muscle hypertrophy.
    The Journal of biological chemistry, 2008, Apr-11, Volume: 283, Issue:15

    Topics: Animals; Asthma; Bronchi; Cytokines; Enzyme Inhibitors; Eukaryotic Initiation Factor-2B; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hypertrophy; Indoles; Lithium Chloride; Maleimides; Mice; Muscle Proteins; Muscle, Smooth; Protein Biosynthesis; RNA, Small Interfering; Signal Transduction

2008